Renoprotective effects of GHRH agonist MR409 is associated with reduced oxidative stress and ferroptosis in diabetic mice
MR409, a synthetic growth hormone-releasing hormone (GHRH) analogue, has demonstrated therapeutic potential in enhancing islet cell transplantation efficacy in diabetes mice and exerts beneficial effects on cardiovascular diseases. The present study investigated the renoprotective effects of MR409 o...
Saved in:
| Main Authors: | Yueyang Liu, Rong Fu, Qi Tang, Yaoxia Zhang, Ruiping Cai, Limin Liu, Hui Jia, Junjia Gao, Ming-Sheng Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1617185/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE ROLE OF OVARIAN SUPPRESSION IN THE TREATMENT OF EARLY-STAGE HORMONE-SENSITIVE BREAST CANCER
by: I. A. Koroleva, et al.
Published: (2018-08-01) -
THE USE OF MODERN ANALOGUES OF LUTEINIZING HORMONE RELEASING HORMONE IN THE HORMONAL THERAPY IN PATIENTS WITH PROSTATE CANCER
by: E. Yu. Safronova, et al.
Published: (2017-06-01) -
DEGARELIX ROLE AND PLACE IN THE COMBINED TREATMENT OF PATIENTS WITH PROSTATE CANCER IN COMBINATION WITH CONCURRENT RADIOTHERAPY
by: A. Y. Pavlov, et al.
Published: (2016-02-01) -
Ferroptosis inducers – erastin and analogues (review)
by: E. V. Sanarova, et al.
Published: (2024-06-01) -
Andrological aspects of the effects of gonadotropinreleasing hormone agonists in experiment and clinic
by: I. V. Maiborodin, et al.
Published: (2024-12-01)